Pathological remodeling of distal lung matrix in end-stage cystic fibrosis patients

被引:6
|
作者
Pinezich, Meghan R. [1 ]
Tamargo, Manuel A. [1 ,2 ]
Fleischer, Sharon [1 ]
Reimer, Jonathan A. [1 ,3 ]
Hudock, Maria R. [1 ]
Hozain, Ahmed E. [1 ,3 ]
Kaslow, Sarah R. [1 ,3 ]
Tipograf, Yuliya [5 ]
Soni, Rajesh Kumar [4 ]
Gavaudan, Olimpia P. [1 ]
Guenthart, Brandon A. [7 ]
Marboe, Charles C. [8 ]
Bacchetta, Matthew [5 ,6 ]
O'Neill, John D. [9 ]
Dorrello, N. Valerio [10 ]
Vunjak-Novakovic, Gordana [1 ,2 ,11 ]
机构
[1] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA
[2] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, Dept Surg, New York, NY USA
[4] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, Prote & Macromol Crystallog Shared Resource, New York, NY USA
[5] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA
[6] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA
[7] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA
[8] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA
[9] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA
[10] Columbia Univ, Irving Med Ctr, Dept Pediat, New York, NY USA
[11] Columbia Univ, Irving Med Ctr, Coll Dent Med, New York, NY USA
关键词
Cystic fibrosis; Extracellular matrix; Lung proteases; Basement membrane; Biomarkers; SPUTUM; METALLOPROTEINASES; CHILDREN; AIRWAY; INFLAMMATION; DESTRUCTION; COLLAGENASE; BIOMARKERS; IMBALANCE; ELASTIN;
D O I
10.1016/j.jcf.2022.04.016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Manifestations of cystic fibrosis, although well-characterized in the proximal airways, are understudied in the distal lung. Characterization of the cystic fibrosis lung "matrisome" (matrix proteome) has not been previously described, and could help identify biomarkers and inform therapeutic strategies. Methods: We performed liquid chromatography-mass spectrometry, gene ontology analysis, and multi-modal imaging, including histology, immunofluorescence, and electron microscopy for a comprehensive evaluation of distal human lung extracellular matrix (matrix) structure and composition in end-stage cystic fibrosis. Results: Quantitative proteomic profiling identified sixty-eight (68) matrix constituents with significantly altered expression in end-stage cystic fibrosis. Over 90% of significantly different matrix peptides detected, including structural and basement membrane proteins, were expressed at lower levels in cystic fibrosis. However, the total abundance of matrix in cystic fibrosis lungs was not significantly different from control lungs, suggesting that cystic fibrosis leads to loss of diversity among lung matrix proteins rather than an absolute loss of matrix. Visualization of distal lung matrix via immunofluorescence and electron microscopy revealed pathological remodeling of distal lung tissue architecture and loss of alveolar basement membrane, consistent with significantly altered pathways identified by gene ontology analysis. Conclusions: Dysregulation of matrix organization and aberrant wound healing pathways are associated with loss of matrix protein diversity and obliteration of distal lung tissue structure in end-stage cystic fibrosis. While many therapeutics aim to functionally restore defective cystic fibrosis transmembrane conductance regulator (CFTR), drugs that target dysregulated matrix pathways may serve as adjunct interventions to support lung recovery. (c) 2022 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1027 / 1035
页数:9
相关论文
共 50 条
  • [21] Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis
    Hayes, Don, Jr.
    Anstead, Michael I.
    Warner, Rena T.
    Kuhn, Robert J.
    Ballard, Hubert O.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (09) : 737 - 740
  • [22] PHYSIOTHERAPY IN END-STAGE CYSTIC FIBROSIS THE ROLE OF HOME CARE
    Parkinson, H. F.
    Reilly, C. C.
    Channon, K.
    Elston, C.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 408 - 408
  • [23] End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis
    Elise J. Lammertyn
    Elly Vandermeulen
    Hannelore Bellon
    Stephanie Everaerts
    Stijn E. Verleden
    Kathleen Van Den Eynde
    Ken R. Bracke
    Guy G. Brusselle
    Pieter C. Goeminne
    Erik K. Verbeken
    Bart M. Vanaudenaerde
    Lieven J. Dupont
    Respiratory Research, 18
  • [24] End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis
    Lammertyn, Elise J.
    Vandermeulen, Elly
    Bellon, Hannelore
    Everaerts, Stephanie
    Verleden, Stijn E.
    Van den Eynde, Kathleen
    Bracke, Ken R.
    Brusselle, Guy G.
    Goeminne, Pieter C.
    Verbeken, Erik K.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    RESPIRATORY RESEARCH, 2017, 18
  • [25] Endogenous and nitrovasodilator-induced release of NO in the airways of end-stage cystic fibrosis patients
    Varga, T.
    Kovesi, T.
    Gal, J.
    Marczin, N.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 682 - 683
  • [26] Prediction Equations Underestimate Resting Energy Expenditure in Patients With End-Stage Cystic Fibrosis
    Hollander, Francis M.
    Kok, Annemieke
    de Roos, Nicole M.
    Belle-van Meerkerk, Gerdien
    van de Graaf, Ed A.
    NUTRITION IN CLINICAL PRACTICE, 2017, 32 (01) : 116 - 121
  • [27] Ethical Dilemma Elexacaftor-Tezacaftor-Ivacaftor or Lung Transplantation in Cystic Fibrosis and End-Stage Lung Disease?
    Breuer, Oded
    Shoseyov, David
    Koretz, Shifra
    Alyan, Nadia
    Reiter, Joel
    Cohen-Cymberknoh, Malena
    Wexler, Isaiah
    Kerem, Eitan
    CHEST, 2022, 161 (03) : 773 - 780
  • [28] Diffuse Cystic Lung Disease: Clinical, Functional, Radiological and Pathological Evaluations from Early-Stage to End-Stage
    Chen, W.
    Dai, H.
    Guo, L.
    Zhao, L.
    Liang, C.
    Jing, L.
    Liu, M.
    Zhao, L.
    Chen, J.
    Wang, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [29] EARLY RESULTS OF SINGLE LUNG TRANSPLANTATION IN PATIENTS WITH END-STAGE PULMONARY FIBROSIS
    MCGREGOR, CGA
    DARK, JH
    HILTON, CJ
    FREEMAN, R
    CONACHER, ID
    CORRIS, PA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1989, 98 (03): : 350 - 354
  • [30] Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer
    Zhang, J.
    Liu, D.
    Chen, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1142 - 1142